Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in the development, manufacture, marketing, and sale of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services. It also provides finance leasing services; and engages in the research, production, and sale of health products, functional foods, and skincare products in the field of soft capsule dosage form.
